News_News_Beijing Holley-Cotec Pharmaceuticals Co., Ltd.

24 2025-01 

KPC Pharmaceuticals, Inc. Delivers Its First Shipment of DUO-COTECXIN® Tablets to The Global Fund to Support Burkina Faso's Fight Against Malaria

Recently, KPC Pharmaceuticals, Inc. received the first order for dihydroartemisinin and piperaquine phosphate tablets (DUO-COTECXIN®) from The Global Fund to Fight AIDS, Tuberculosis and Malaria.

19 2023-10 

Dihydroartemisinin/Piperaquine phosphate tablet from KPC secures WHO prequalification approval

Beijing Holley-Cotec Pharmaceuticals Co., Ltd. has received prequalification approval from the World Health Organization (WHO) for its antimalarial product, dihydroartemisinin/Piperaquine phosphate 40mg/320mg film-coated tablet (DHA/PQP tablet, under the proprietary name of Duo-Cotecxin) .

26 2023-04 

‘World Malaria Day Scientific Colloquium’ held in Kampala, Uganda

On April 21st, 2023, Sales Team from Super Pharmaceuticals Limited, a subsidiary company of KPC Pharmaceuticals Inc., participated in the ‘World Malaria Day Scientific Colloquium’ held in Kampala, Uganda.

21 2022-06 

The 2021 Vietnam Annual Academic Conference of Luotai series products was grandly held

On June 18th - 21th 2022, the Vietnam annual academic conference of Luotai Panax notoginseng series products was grandly held in Viet Halong Bay.

26 2022-04 

KPC Pharmaceuticals, Inc. was invited to participate in the International Forum on the 50th Anniversary of the Discovery of Artemisinin and on Building a Global Community of Health for All

25th April 2022, International Forum on the 50th Anniversary of the Discovery of Artemisinin and on Building a Global Community of Health for All was jointly held by China International Development Cooperation Agency (CIDCA), National Health Commission of China(NHC), National Administration Of Traditional Chinese Medicine(NATCM) at Diaoyutai State Guest House.

NEWS